THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. financial data

Location
Elk City, ID
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2024 - 20 Nov 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 30% % 174%
Quick Ratio 1% % -37%
Debt-to-equity 156% % -7.9%
Return On Equity -142% % 33%
Return On Assets -66% % 18%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5,122,705,536 shares
Common Stock, Shares, Outstanding 5,057,149,981 shares 47%
Common Stock, Value, Issued $5,057,151 USD 47%
Weighted Average Number of Shares Outstanding, Basic 4,913,103,351 shares 49%
Weighted Average Number of Shares Outstanding, Diluted 4,913,103,351 shares 49%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $85,319 USD 1.9%
Research and Development Expense $242,743 USD -65%
General and Administrative Expense $456,376 USD -2.6%
Operating Income (Loss) $3,593,571 USD -50%
Nonoperating Income (Expense) $148,937 USD 70%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $3,742,508 USD -30%
Income Tax Expense (Benefit) $800 USD 0%
Net Income (Loss) Attributable to Parent $2,410,213 USD 14%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $9,233 USD -90%
Accounts Receivable, after Allowance for Credit Loss, Current $17,043 USD -22%
Inventory, Net $17,151 USD -35%
Other Assets, Current $2,479,483 USD
Assets, Current $498,747 USD 176%
Property, Plant and Equipment, Net $366,195 USD -2.9%
Operating Lease, Right-of-Use Asset $105,505 USD -20%
Other Assets, Noncurrent $2,630,039 USD -5.5%
Assets $3,600,486 USD 3.6%
Accrued Liabilities, Current $571,676 USD -5%
Liabilities, Current $1,838,596 USD -10%
Operating Lease, Liability, Noncurrent $78,733 USD -25%
Liabilities $1,918,773 USD -11%
Retained Earnings (Accumulated Deficit) $22,309,186 USD -15%
Stockholders' Equity Attributable to Parent $1,238,007 USD -5.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $1,681,713 USD 28%
Liabilities and Equity $3,600,486 USD 3.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $205,509 USD -2.2%
Net Cash Provided by (Used in) Financing Activities $231,163 USD 16%
Common Stock, Shares Authorized 6,500,000,000 shares 18%
Common Stock, Shares, Issued 5,057,149,981 shares 47%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $25,654 USD 5125%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $53,477 USD 81%
Interest Paid, Excluding Capitalized Interest, Operating Activities $269 USD -59%
Operating Lease, Liability $105,505 USD -20%
Depreciation $2,720 USD 0%
Property, Plant and Equipment, Gross $413,517 USD 0%
Operating Lease, Liability, Current $26,772 USD -0.05%
Operating Lease, Weighted Average Discount Rate, Percent 0.01 pure -80%
Preferred Stock, Shares Issued 1,002 shares 50000%
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Additional Paid in Capital $18,511,041 USD 7.1%
Preferred Stock, Shares Outstanding 1,002 shares 50000%
Amortization of Intangible Assets $74,194 USD 0%
Interest Expense $390,643 USD -37%